PURPOSE: Biodegradable elastomers, which can possess favorable mechanical properties and degradation rates for soft tissue engineering applications, are more recently being explored as depots for biomolecule delivery. The objective of this study was to synthesize and process biodegradable, elastomeric poly(ester urethane)urea (PEUU) scaffolds and to characterize their ability to incorporate and release bioactive insulin-like growth factor-1 (IGF-1) and hepatocyte growth factor (HGF). METHODS: Porous PEUU scaffolds made from either 5 or 8 wt% PEUU were prepared with direct growth-factor incorporation. Long-term in vitro IGF-1 release kinetics were investigated in saline or saline with 100 units/ml lipase to simulate in vivo degradation. Cellular assays were used to confirm released IGF-1 and HGF bioactivity. RESULTS: IGF-1 release into saline occurred in a complex multi-phasic manner for up to 440 days. Scaffolds generated from 5 wt% PEUU delivered protein faster than 8 wt% scaffolds. Lipase-accelerated scaffold degradation led to delivery of >90% protein over 9 weeks for both polymer concentrations. IGF-1 and HGF bioactivity in the first 3 weeks was confirmed. CONCLUSIONS: The capacity of a biodegradable elastomeric scaffold to provide long-term growth-factor delivery was demonstrated. Such a system might provide functional benefit in cardiovascular and other soft tissue engineering applications.
PURPOSE: Biodegradable elastomers, which can possess favorable mechanical properties and degradation rates for soft tissue engineering applications, are more recently being explored as depots for biomolecule delivery. The objective of this study was to synthesize and process biodegradable, elastomeric poly(ester urethane)urea (PEUU) scaffolds and to characterize their ability to incorporate and release bioactive insulin-like growth factor-1 (IGF-1) and hepatocyte growth factor (HGF). METHODS: Porous PEUU scaffolds made from either 5 or 8 wt% PEUU were prepared with direct growth-factor incorporation. Long-term in vitro IGF-1 release kinetics were investigated in saline or saline with 100 units/ml lipase to simulate in vivo degradation. Cellular assays were used to confirm released IGF-1 and HGF bioactivity. RESULTS:IGF-1 release into saline occurred in a complex multi-phasic manner for up to 440 days. Scaffolds generated from 5 wt% PEUU delivered protein faster than 8 wt% scaffolds. Lipase-accelerated scaffold degradation led to delivery of >90% protein over 9 weeks for both polymer concentrations. IGF-1 and HGF bioactivity in the first 3 weeks was confirmed. CONCLUSIONS: The capacity of a biodegradable elastomeric scaffold to provide long-term growth-factor delivery was demonstrated. Such a system might provide functional benefit in cardiovascular and other soft tissue engineering applications.
Authors: Christopher E Nelson; Mukesh K Gupta; Elizabeth J Adolph; Joshua M Shannon; Scott A Guelcher; Craig L Duvall Journal: Biomaterials Date: 2011-11-05 Impact factor: 12.479
Authors: Zuwei Ma; Yi Hong; Devin M Nelson; Joseph E Pichamuthu; Cory E Leeson; William R Wagner Journal: Biomacromolecules Date: 2011-07-26 Impact factor: 6.988
Authors: Antonio D'Amore; Marco Fazzari; Hong-Bin Jiang; Samuel K Luketich; Michael E Luketich; Richard Hoff; Daniel L Jacobs; Xinzhu Gu; Stephen F Badylak; Bruce A Freeman; William R Wagner Journal: Tissue Eng Part A Date: 2018-02-27 Impact factor: 3.845
Authors: Matthew T Wolf; Yoram Vodovotz; Stephen Tottey; Bryan N Brown; Stephen F Badylak Journal: Tissue Eng Part C Methods Date: 2014-08-04 Impact factor: 3.056
Authors: Christopher E Nelson; Arnold J Kim; Elizabeth J Adolph; Mukesh K Gupta; Fang Yu; Kyle M Hocking; Jeffrey M Davidson; Scott A Guelcher; Craig L Duvall Journal: Adv Mater Date: 2013-12-16 Impact factor: 30.849
Authors: Matthew T Wolf; Christopher L Dearth; Sonya B Sonnenberg; Elizabeth G Loboa; Stephen F Badylak Journal: Adv Drug Deliv Rev Date: 2014-08-29 Impact factor: 15.470